Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2.
Jeremiah SS, Moin ASM, Butler AE.
Metabolism. 2024 Jul;156:155917. doi: 10.1016/j.metabol.2024.155917. Epub 2024 Apr 18.
Drug-Induced Hyperglycaemia and Diabetes.
Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C.
Drug Saf. 2015 Dec;38(12):1153-68. doi: 10.1007/s40264-015-0339-z.
COVID-19 and diabetes: A bidirectional relationship.
Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M.
Clin Investig Arterioscler. 2021 May-Jun;33(3):151-157. doi: 10.1016/j.arteri.2020.10.001. Epub 2020 Oct 28.
Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes.
Nobs SP, Kolodziejczyk AA, Adler L, Horesh N, Botscharnikow C, Herzog E, Mohapatra G, Hejndorf S, Hodgetts RJ, Spivak I, Schorr L, Fluhr L, Kviatcovsky D, Zacharia A, Njuki S, Barasch D, Stettner N, Dori-Bachash M, Harmelin A, Brandis A, Mehlman T, Erez A, He Y, Ferrini S, Puschhof J, Shapiro H, Kopf M, Moussaieff A, Abdeen SK, Elinav E.
Nature. 2023 Dec;624(7992):645-652. doi: 10.1038/s41586-023-06803-0. Epub 2023 Dec 13.
New onset diabetes, type 1 diabetes and COVID-19.
Boddu SK, Aurangabadkar G, Kuchay MS.
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2211-2217. doi: 10.1016/j.dsx.2020.11.012. Epub 2020 Nov 17.
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
Vallianou NG, Evangelopoulos A, Kounatidis D, Stratigou T, Christodoulatos GS, Karampela I, Dalamaga M.
Curr Diabetes Rev. 2021;17(6):e123120189797. doi: 10.2174/1573399817666210101110253.
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM.
Cell Metab. 2020 Sep 1;32(3):437-446.e5. doi: 10.1016/j.cmet.2020.07.007. Epub 2020 Jul 17.
Coronavirus infection in patients with diabetes.
Torres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, Martínez-Alvarado MDR.
Arch Cardiol Mex. 2020;90(Supl):67-76. doi: 10.24875/ACM.M20000068.
COVID-19-Induced New-Onset Diabetes: Trends and Technologies.
Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP.
Diabetes. 2021 Dec;70(12):2733-2744. doi: 10.2337/dbi21-0029. Epub 2021 Oct 22.
Pathology of Diabetes-Induced Immune Dysfunction.
Alexander M, Cho E, Gliozheni E, Salem Y, Cheung J, Ichii H.
Int J Mol Sci. 2024 Jun 28;25(13):7105. doi: 10.3390/ijms25137105.
